Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in J Pediatr Hematol Oncol

Retrieve available abstracts of 158 articles:
HTML format
Text format



Single Articles


    August 2018
  1. RAJPURKAR M, Alonzo TA, Wang YC, Gerbing RB, et al
    Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
    J Pediatr Hematol Oncol. 2018 Aug 8. doi: 10.1097/MPH.0000000000001280.
    PubMed     Text format     Abstract available


  2. REINECKE J, Lowas S, Snowden J, Neemann K, et al
    Blood Stream Infections and Antibiotic Utilization in Pediatric Leukemia Patients With Febrile Neutropenia.
    J Pediatr Hematol Oncol. 2018 Aug 8. doi: 10.1097/MPH.0000000000001279.
    PubMed     Text format     Abstract available


  3. BELLE FN, Kasteler R
    Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Aug 4. doi: 10.1097/MPH.0000000000001286.
    PubMed     Text format    


    July 2018
  4. POUKKA M, Lund-Aho T, Raittinen P, Nikkila A, et al
    Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment.
    J Pediatr Hematol Oncol. 2018 Jul 24. doi: 10.1097/MPH.0000000000001267.
    PubMed     Text format     Abstract available


  5. YAMADA A, Kinoshita M, Sawa D, Saito Y, et al
    Long-term Remission of Acute Myeloid Leukemia Developed From Systemic Mastocytosis by Conventional Chemotherapy.
    J Pediatr Hematol Oncol. 2018 Jul 23. doi: 10.1097/MPH.0000000000001259.
    PubMed     Text format     Abstract available


  6. MANKUZHY NP, Walling E, Anderson B, Mody R, et al
    Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Jul 19. doi: 10.1097/MPH.0000000000001249.
    PubMed     Text format     Abstract available


    June 2018
  7. PALEN K, Thakar M, Johnson BD, Gershan JA, et al
    Bone Marrow-derived CD8+ T Cells From Pediatric Leukemia Patients Express PD1 and Expand Ex Vivo Following Induction Chemotherapy.
    J Pediatr Hematol Oncol. 2018 Jun 14. doi: 10.1097/MPH.0000000000001244.
    PubMed     Text format     Abstract available


  8. RAE C, Furlong W, Feeny D, Couchman R, et al
    Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol.
    J Pediatr Hematol Oncol. 2018 Jun 12. doi: 10.1097/MPH.0000000000001235.
    PubMed     Text format     Abstract available


  9. KIM BK, Hong KT, Kang HJ, An HY, et al
    Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.
    J Pediatr Hematol Oncol. 2018 Jun 8. doi: 10.1097/MPH.0000000000001237.
    PubMed     Text format     Abstract available


    May 2018
  10. VEDI A, Mitchell R, Shanmuganathan S, Oswald C, et al
    Increased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse Treatment.
    J Pediatr Hematol Oncol. 2018 May 22. doi: 10.1097/MPH.0000000000001215.
    PubMed     Text format     Abstract available


  11. KRAMER M, Antony R, Ozturk A, Lehn K, et al
    A Palpable Back Mass as First Presenting Sign of Acute Lymphoblastic Leukemia in a Pediatric Patient.
    J Pediatr Hematol Oncol. 2018 May 10. doi: 10.1097/MPH.0000000000001214.
    PubMed     Text format    


  12. YOUNG J, Welin E, Braeutigam C, Gilger E, et al
    Impact of a Vitamin D Replacement Algorithm in Children and Young Adults With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 May 4. doi: 10.1097/MPH.0000000000001204.
    PubMed     Text format     Abstract available


  13. MCNEIL MJ, Parisi MT, Hijiya N, Meshinchi S, et al
    Clinical and Radiographic Response of Extramedullary Leukemia in Patients Treated With Gemtuzumab Ozogamicin.
    J Pediatr Hematol Oncol. 2018 May 4. doi: 10.1097/MPH.0000000000001201.
    PubMed     Text format     Abstract available


    April 2018
  14. HASHII Y, Yoshida M, Hara J, Nishimura S, et al
    Acid-suppressing Drugs and a Low 1 Level of Antithrombin as Risk Factors for L-Asparaginase-associated Pancreatitis: A Case-control Study in the Japan Association of Childhood Leukemia Study (JACLS).
    J Pediatr Hematol Oncol. 2018 Apr 24. doi: 10.1097/MPH.0000000000001193.
    PubMed     Text format     Abstract available


  15. SUN B, Xia Z, Cai F, Wang P, et al
    APRIL is Involved in the Proliferation and Metastasis of Acute Lymphoblastic Leukemia Cells.
    J Pediatr Hematol Oncol. 2018 Apr 24. doi: 10.1097/MPH.0000000000001198.
    PubMed     Text format     Abstract available


  16. PLOTKA A, Wziatek A, Wachowiak J, Derwich K, et al
    Successful Management of a Child With Drug-induced Necrotizing Pancreatitis During Acute Lymphoblastic Leukemia Therapy: A Case Report.
    J Pediatr Hematol Oncol. 2018 Apr 20. doi: 10.1097/MPH.0000000000001181.
    PubMed     Text format     Abstract available


  17. ELDEM I, Yavuz D, Cumaogullari O, Ileri T, et al
    SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy.
    J Pediatr Hematol Oncol. 2018 Apr 20. doi: 10.1097/MPH.0000000000001153.
    PubMed     Text format     Abstract available


  18. MEZA-ARROYO J, Bravo-Cuellar A, Jave-Suarez LF, Hernandez-Flores G, et al
    Pentoxifylline Added to Steroid Window Treatment Phase Modified Apoptotic Gene Expression in Pediatric Patients With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Apr 20. doi: 10.1097/MPH.0000000000001152.
    PubMed     Text format     Abstract available


  19. BOKLAN JL, Walsh AM, de la Maza MC, Su LL, et al
    Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.
    J Pediatr Hematol Oncol. 2018 Apr 17. doi: 10.1097/MPH.0000000000001154.
    PubMed     Text format     Abstract available


  20. BECKTELL K, Houser K, Burke MJ
    Epigenetic Therapy in a Patient With Down Syndrome and Refractory Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2018 Apr 17. doi: 10.1097/MPH.0000000000001158.
    PubMed     Text format     Abstract available


  21. BOULANGER C, de Ville de Goyet M, de Magnee C, Dupont S, et al
    Multiple Epstein-Barr Virus-associated Smooth Muscle Sarcomas of the Gut in a Child Treated for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Apr 17. doi: 10.1097/MPH.0000000000001179.
    PubMed     Text format     Abstract available


  22. DE MATTEO A, Petruzziello F, Parasole R, Esposito A, et al
    Quantitative Ultrasound of Proximal Phalanxes in Childhood Acute Lymphoblastic Leukemia Survivors.
    J Pediatr Hematol Oncol. 2018 Apr 3. doi: 10.1097/MPH.0000000000001146.
    PubMed     Text format     Abstract available


  23. FRIESENBICHLER W, Schumich A, Simonitsch-Klupp I, Panzer-Grumayer R, et al
    Concurrent Acute Myelofibrosis and Acute Lymphoblastic Leukemia in Childhood: Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2018;40:235-237.
    PubMed     Text format     Abstract available


    March 2018
  24. MALHOTRA P, Jain S, Kapoor G
    Symptomatic Cerebral Sinovenous Thrombosis Associated With L-Asparaginase In Children With Acute Lymphoblastic Leukemia: A Single Institution Experience Over 17 Years.
    J Pediatr Hematol Oncol. 2018 Mar 16. doi: 10.1097/MPH.0000000000001127.
    PubMed     Text format     Abstract available


    February 2018
  25. TUFEKCI O, Erdem M, Oren H, Yilmaz S, et al
    Cup-like Blasts in 2 Pediatric Patients With NPM-1-Positive Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2018 Feb 9. doi: 10.1097/MPH.0000000000001110.
    PubMed     Text format     Abstract available


  26. FERRI GM, Guastadisegno CM, Intranuovo G, Cavone D, et al
    Maternal Exposure to Pesticides, Paternal Occupation in the Army/Police Force, and CYP2D6*4 Polymorphism in the Etiology of Childhood Acute Leukemia.
    J Pediatr Hematol Oncol. 2018 Feb 9. doi: 10.1097/MPH.0000000000001105.
    PubMed     Text format     Abstract available


  27. RAIKAR SS, Felker J, Patel KN, Lew G, et al
    Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature.
    J Pediatr Hematol Oncol. 2018 Feb 2. doi: 10.1097/MPH.0000000000001114.
    PubMed     Text format     Abstract available


  28. SEKI Y, Okamoto Y, Kodama Y, Nishikawa T, et al
    Risk Factors and the Prevention of Weight Gain During Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Feb 2. doi: 10.1097/MPH.0000000000001098.
    PubMed     Text format     Abstract available


    January 2018
  29. BEROT A, Pluchart C
    Treatment With Azacitidine in the Context of Palliative Care for a Patient With Acute Myeloid Leukemia Complicating Fanconi Anemia With Biallelic FANCD1/BRCA 2 Mutations.
    J Pediatr Hematol Oncol. 2018 Jan 31. doi: 10.1097/MPH.0000000000001090.
    PubMed     Text format    


  30. HEATH JL, Aumann WK, Maxfield CM, Wechsler DS, et al
    Isolated Central Nervous System Chloroma as a Presenting Sign of Relapsed Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2018 Jan 12. doi: 10.1097/MPH.0000000000001085.
    PubMed     Text format     Abstract available


  31. GOSSAI N, Richards M, Boman L, Messinger Y, et al
    Symptomatic Hyperammonemia With Erwinia chrysanthemi-derived Asparaginase in Pediatric Leukemia Patients.
    J Pediatr Hematol Oncol. 2018 Jan 12. doi: 10.1097/MPH.0000000000001062.
    PubMed     Text format     Abstract available


  32. SHAHEEN N, Mussai F
    Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab.
    J Pediatr Hematol Oncol. 2018 Jan 8. doi: 10.1097/MPH.0000000000001077.
    PubMed     Text format     Abstract available


  33. PANA ZD, Kourti M, Vikelouda K, Vlahou A, et al
    Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study.
    J Pediatr Hematol Oncol. 2018;40:22-26.
    PubMed     Text format     Abstract available


  34. BORRETTA L, MacDonald T, Digout C, Smith N, et al
    Peripherally Inserted Central Catheters in Pediatric Oncology Patients: A 15-Year Population-based Review From Maritimes, Canada.
    J Pediatr Hematol Oncol. 2018;40:e55-e60.
    PubMed     Text format     Abstract available


  35. MIZIA-MALARZ A, Sobol-Milejska G
    Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location.
    J Pediatr Hematol Oncol. 2018;40:e29-e31.
    PubMed     Text format     Abstract available


    December 2017
  36. USER IR, Akbayram S, Ozokutan BH
    Clinical Presentation, Prognostic Factors, and Outcome in Neutropenic Enteropathy of Childhood Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 29. doi: 10.1097/MPH.0000000000001065.
    PubMed     Text format     Abstract available


  37. HILL R, Bricker M, Bashore L, Rapisand S, et al
    Weight Gain in Pediatric Acute Lymphoblastic Leukemia Patients With Down Syndrome.
    J Pediatr Hematol Oncol. 2017 Dec 29. doi: 10.1097/MPH.0000000000001066.
    PubMed     Text format    


  38. NAKAGAWA S, Okamoto Y, Kodama Y, Nishikawa T, et al
    Thiamylal Plus Pentazocine Shows Similar Efficacy as Ketamine Plus Midazolam for Painful Procedures in Children With Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 12. doi: 10.1097/MPH.0000000000001053.
    PubMed     Text format     Abstract available


  39. LIU AP, Leung AW, Cheuk DK, Lee V, et al
    Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children.
    J Pediatr Hematol Oncol. 2017 Dec 12. doi: 10.1097/MPH.0000000000001010.
    PubMed     Text format    


  40. KOUZUKI K, Umeda K, Saida S, Kato I, et al
    Sudden Intracranial Hemorrhage in a Patient With Atypical Chronic Myeloid Leukemia in Chronic Phase.
    J Pediatr Hematol Oncol. 2017 Dec 8. doi: 10.1097/MPH.0000000000001061.
    PubMed     Text format     Abstract available


  41. PEKPAK E, Ileri T, Ince E, Ertem M, et al
    Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 6. doi: 10.1097/MPH.0000000000001022.
    PubMed     Text format     Abstract available


  42. DE LEONARDIS F, Koronica R, Daniele RM, Santoro N, et al
    Thrombotic Thrombocytopenic Purpura in a Child Treated for Acute Lymphoblastic Leukemia: Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2017 Dec 6. doi: 10.1097/MPH.0000000000001050.
    PubMed     Text format     Abstract available


  43. TSUJIMOTO SI, Nakano Y, Osumi T, Okada K, et al
    A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 6. doi: 10.1097/MPH.0000000000001007.
    PubMed     Text format     Abstract available


  44. BERGER-ACHITUV S, Elhasid R
    Reduced Neutrophil Elastase Activity and Neutrophil Extracellular Traps in Pediatric Acute Myeloid Leukemia May Increase the Rate of Infections.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001015.
    PubMed     Text format     Abstract available


  45. WANG YM, Nudleman E, Vinocur D, Kuo DJ, et al
    Terson Syndrome Before Induction Chemotherapy for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001047.
    PubMed     Text format     Abstract available


  46. ABAZA HM, Alfeky MAA, Eissa DS, Abdel Fattah MF, et al
    Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001008.
    PubMed     Text format     Abstract available


  47. HONG KT, Choi JY, Hong CR, Kang HJ, et al
    Therapy-related Acute Myeloid Leukemia After the Treatment of Primary Solid Cancer in Children: A Single-center Experience.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001019.
    PubMed     Text format     Abstract available


  48. VALLIYAMMAI N, Nancy NK, Sagar TG, Rajkumar T, et al
    Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001006.
    PubMed     Text format     Abstract available


  49. BANERJEE JS, Heyman M, Palomaki M, Lahteenmaki P, et al
    Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001009.
    PubMed     Text format     Abstract available


    November 2017
  50. DAS A, Oberoi S, Trehan A, Chakrabarti A, et al
    Invasive Fungal Disease in Pediatric Acute Leukemia in the Nontransplant Setting: 8 Years' Experience From a Tertiary Care Center in North India.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000001027.
    PubMed     Text format     Abstract available



  51. Drug Rash, Eosinophilia, Systemic Symptoms (DRESS) in a Child With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000001031.
    PubMed     Text format    


  52. CANNATA E, Samperi P, Cimino C, Marino S, et al
    Successful Treatment of a Very Late Isolated Relapse in an Adolescent With a PICALM-MLLT10 Positive T-lineage Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000000996.
    PubMed     Text format     Abstract available


  53. BAKK I, Koch T, Stanek J, O'Brien SH, et al
    Steroid-induced Hypertension During Induction Chemotherapy for Acute Lymphoblastic Leukemia in US Children's Hospitals.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000000997.
    PubMed     Text format     Abstract available


  54. FELIX A, Leblanc T, Petit A, Nelkem B, et al
    Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
    J Pediatr Hematol Oncol. 2017 Nov 17. doi: 10.1097/MPH.0000000000001034.
    PubMed     Text format     Abstract available


  55. MOSAKHANI N, Missiry ME, Vakkila E, Knuutila S, et al
    Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017;39:585-588.
    PubMed     Text format     Abstract available


  56. DANG BN, De Oliveira S, Bowles L, Moore TB, et al
    Isolated Testicular Recurrence of AML in Patients With Chronic GVHD >1 Year Following Allogeneic Stem Cell Transplant.
    J Pediatr Hematol Oncol. 2017;39:e423-e425.
    PubMed     Text format     Abstract available


  57. SHAUKAT H, O'Mara J, Neier M
    A Pediatric Case of Persistent Thrombocytopenia in a Patient Who Developed All.
    J Pediatr Hematol Oncol. 2017;39:e512-e514.
    PubMed     Text format     Abstract available


  58. EROGLU N, Bahadir A, Erduran E
    A Case of ALL Developing Posterior Reversible Encephalopathy Secondary to Hyponatremia.
    J Pediatr Hematol Oncol. 2017;39:e476-e478.
    PubMed     Text format     Abstract available


    October 2017
  59. HILL R, Hamby T, Bashore L, Rapisand S, et al
    Early Nutrition Intervention Attenuates Weight Gain for Pediatric Acute Lymphoblastic Leukemia Patients in Maintenance Therapy.
    J Pediatr Hematol Oncol. 2017 Oct 17. doi: 10.1097/MPH.0000000000000975.
    PubMed     Text format     Abstract available


  60. VATSAYAN A, Talati R, Nagle K, Cabral L, et al
    Complete Resolution of Lymphoid Interstitial Pneumonia in a Patient With Juvenile Myelomonocytic Leukemia Treated With Allogeneic Bone Marrow Transplant: Killing 2 Birds With 1 Stone.
    J Pediatr Hematol Oncol. 2017 Oct 11. doi: 10.1097/MPH.0000000000000977.
    PubMed     Text format     Abstract available


  61. ERKER C, Huppler AR, Walsh TJ, McCormick ME, et al
    Successful Treatment of Invasive Conidiobolus Infection During Therapy for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Oct 5. doi: 10.1097/MPH.0000000000000985.
    PubMed     Text format     Abstract available


  62. CHENG G, Ozgonenel B, Bhambhani K, Kapur G, et al
    Recurrent Atypical Hemolytic Uremic Syndrome in Children With Acute Lymphoblastic Leukemia Undergoing Maintenance Chemotherapy.
    J Pediatr Hematol Oncol. 2017 Oct 4. doi: 10.1097/MPH.0000000000000987.
    PubMed     Text format     Abstract available


  63. ESTEPP JH, Smeltzer MP, Kang G, Howard SC, et al
    Safe Use of Low-Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures.
    J Pediatr Hematol Oncol. 2017 Oct 4. doi: 10.1097/MPH.0000000000000988.
    PubMed     Text format     Abstract available


  64. KIM MJ, Nasr A, Kabir B, de Nanassy J, et al
    Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
    J Pediatr Hematol Oncol. 2017;39:528-537.
    PubMed     Text format     Abstract available


  65. KIZILOCAK H, Dikme G, Ozdemir N, Kurugoglu S, et al
    Sinusoidal Obstruction Syndrome During Chemotherapy of Pediatric Cancers and its Successful Management With Defibrotide.
    J Pediatr Hematol Oncol. 2017;39:e373-e376.
    PubMed     Text format     Abstract available


  66. CHEYUO C, Radwan W, Ahn J, Gyure K, et al
    Biallelic PMS2 Mutation and Heterozygous DICER1 Mutation Presenting as Constitutional Mismatch Repair Deficiency With Corpus Callosum Agenesis: Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2017;39:e381-e387.
    PubMed     Text format     Abstract available


    September 2017
  67. FELICE MS, Rossi JG, Alonso CN, Rubio P, et al
    Second Neoplasms in Children Following a Treatment for Acute Leukemia and/or Lymphoma: 29 Years of Experience in a Single Institution in Argentina.
    J Pediatr Hematol Oncol. 2017 Sep 22. doi: 10.1097/MPH.0000000000000971.
    PubMed     Text format     Abstract available


  68. DEGNIN M, Agarwal A, Tarlock K, Meshinchi S, et al
    Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens.
    J Pediatr Hematol Oncol. 2017 Sep 12. doi: 10.1097/MPH.0000000000000946.
    PubMed     Text format     Abstract available


  69. WHITTLE SB, Punia JN, Lopez-Terrada D, Gaikwad A, et al
    Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma.
    J Pediatr Hematol Oncol. 2017 Sep 8. doi: 10.1097/MPH.0000000000000956.
    PubMed     Text format     Abstract available


    August 2017
  70. MARTINEZ-ROMERA I, Villa M, Areal P, Rodrigo E, et al
    Hemophagocytic Lymphohistiocytosis: A Dangerous Intruder in Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Aug 30. doi: 10.1097/MPH.0000000000000932.
    PubMed     Text format     Abstract available


  71. MCNEW BR, Darbro BW, Ma D, Gordon DJ, et al
    Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.
    J Pediatr Hematol Oncol. 2017 Aug 14. doi: 10.1097/MPH.0000000000000924.
    PubMed     Text format     Abstract available


  72. OLCAY L, Serteser M, Kolay M, Balci HF, et al
    The Impact of Iron Overload in Acute Leukemia: Chronic Inflammation, But Not the Presence of Nontransferrin Bound Iron is a Determinant of Oxidative Stress.
    J Pediatr Hematol Oncol. 2017;39:425-439.
    PubMed     Text format     Abstract available


  73. LASHKARI HP, Fernandes N, Alva K, Rai S, et al
    Central Nervous System Fungal Infection and Acute Lymphoblastic Leukemia in Children: What is the Optimal Duration of Antifungal Therapy?
    J Pediatr Hematol Oncol. 2017;39:e312-e317.
    PubMed     Text format     Abstract available


  74. KAYILIOGLU H, Kocak U, Kan Karaer D, Percin EF, et al
    Association of CYP3A5 Expression and Vincristine Neurotoxicity in Pediatric Malignancies in Turkish Population.
    J Pediatr Hematol Oncol. 2017;39:458-462.
    PubMed     Text format     Abstract available


    July 2017
  75. SCHRAW JM, Henson AT, Scheurer ME, Forman MR, et al
    The Associations of Height-for-Age, Weight-for-Age, and Weight-for-Height With Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jul 20. doi: 10.1097/MPH.0000000000000874.
    PubMed     Text format     Abstract available


  76. GERVASINI G, de Murillo SG, Jimenez M, de la Maya MD, et al
    Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.
    J Pediatr Hematol Oncol. 2017 Jul 17. doi: 10.1097/MPH.0000000000000908.
    PubMed     Text format     Abstract available


  77. DE LEONARDIS F, Perillo T, Daniele RM, Santoro N, et al
    Cytomegalovirus Cavitary Pneumonia in Nontransplant Pediatric Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2017 Jul 10. doi: 10.1097/MPH.0000000000000901.
    PubMed     Text format     Abstract available


  78. IQBAL A, Weinstein J, Angelova V, Dighe D, et al
    A Rare Case of Spontaneous Remission of Terminal Deoxynucleotidyl Transferase Negative B-acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jul 3. doi: 10.1097/MPH.0000000000000906.
    PubMed     Text format     Abstract available


  79. SHIGEMURA T, Motobayashi M, Matsuda K, Shimodaira T, et al
    Acute Myeloid Leukemia in a Patient With X-linked Severe Combined Immunodeficiency.
    J Pediatr Hematol Oncol. 2017 Jul 3. doi: 10.1097/MPH.0000000000000892.
    PubMed     Text format     Abstract available


  80. SCHRAW JM, Henson AT, Scheurer ME, Forman MR, et al
    The Associations of Height-for-Age, Weight-for-Age, and Weight-for-Height With Pediatric Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017;39:376-381.
    PubMed     Text format     Abstract available


    June 2017
  81. TUFEKCI O, Yilmaz Bengoa S, Erdem M, Oren H, et al
    Induction Failure in Acute Leukemia or Parvovirus B19 Infection?
    J Pediatr Hematol Oncol. 2017 Jun 29. doi: 10.1097/MPH.0000000000000866.
    PubMed     Text format     Abstract available


    May 2017
  82. GLASSER CL, Lee A, Eslin D, Marks L, et al
    Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.
    J Pediatr Hematol Oncol. 2017 May 29. doi: 10.1097/MPH.0000000000000868.
    PubMed     Text format     Abstract available


  83. MOOIJ CF, van Alfen-van der Velden JAEM, Netea-Maier RT, Ten Broek R, et al
    Pancytopenia and Hypothyroidism in a Patient With Leukemic Infiltration of the Thyroid as the First Presentation of Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 May 29. doi: 10.1097/MPH.0000000000000869.
    PubMed     Text format     Abstract available


  84. GOPAKUMAR KG, Thankamony P, Nampoothiri S, Bali D, et al
    Wolman Disease: A Mimic of Infant Leukemia.
    J Pediatr Hematol Oncol. 2017 May 23. doi: 10.1097/MPH.0000000000000861.
    PubMed     Text format     Abstract available


  85. FUKANO R, Sunami S, Sekimizu M, Takimoto T, et al
    Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
    J Pediatr Hematol Oncol. 2017 May 22. doi: 10.1097/MPH.0000000000000850.
    PubMed     Text format     Abstract available


  86. BENITEZ LL, Gharibian K, Frame D, Mody R, et al
    Clofarabine Dosing in a Patient With Acute Myeloid Leukemia on Intermittent Hemodialysis: Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2017 May 22. doi: 10.1097/MPH.0000000000000845.
    PubMed     Text format     Abstract available


  87. JONES GL, McClellan W, Raman S, Sherman A, et al
    Parental Perceptions of Obesity and Obesity Risk Associated With Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 May 22. doi: 10.1097/MPH.0000000000000852.
    PubMed     Text format     Abstract available


  88. RAO Y, Wu Y, Dong A, Zhu K, et al
    Disseminated Nonleukemic Myeloid Sarcoma of the Spleen With Involvement of the Liver in an Infant.
    J Pediatr Hematol Oncol. 2017;39:e233-e235.
    PubMed     Text format     Abstract available


    April 2017
  89. SCHLOEMER NJ, Brickler M, Hoffmann R, Pan A, et al
    Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes.
    J Pediatr Hematol Oncol. 2017 Apr 27. doi: 10.1097/MPH.0000000000000838.
    PubMed     Text format     Abstract available


    March 2017
  90. BEN MAHMOUD L, Mdhaffar M, Ghozzi H, Ammar M, et al
    Oxidative Stress in Tunisian Patients With Acute Lymphoblastic Leukemia and Its Involvement in Leukemic Relapse.
    J Pediatr Hematol Oncol. 2017 Mar 16. doi: 10.1097/MPH.0000000000000793.
    PubMed     Text format     Abstract available


  91. ARIKAN K, Ozsurekci Y, Ceyhan M
    Bullous Pyoderma Gangrenosum as the Presenting Sign of Acute Myeloid Leukemia in a Child.
    J Pediatr Hematol Oncol. 2017 Mar 6. doi: 10.1097/MPH.0000000000000796.
    PubMed     Text format    


  92. ARIKAN K, Ozsurekci Y, Ceyhan M
    Bullous Pyoderma Gangrenosum as the Presenting Sign of Acute Myeloid Leukemia in a Child.
    J Pediatr Hematol Oncol. 2017 Mar 6. doi: 10.1097/MPH.0000000000000795.
    PubMed     Text format    


  93. BORGES ML, Capela de Matos RR, Amaral BD, Soares-Ventura EM, et al
    Molecular Cytogenetic Approach to Characterize Novel and Cryptic Chromosome Abnormalities in Childhood Myeloid Malignances of Fanconi Anemia.
    J Pediatr Hematol Oncol. 2017;39:e85-e91.
    PubMed     Text format     Abstract available


  94. FRAINT E, Miller R, Walter A
    Posterior Reversible Encephalopathy Syndrome and Cerebral Sinus Thrombosis in a Case of Pediatric B-Cell ALL.
    J Pediatr Hematol Oncol. 2017;39:e71-e73.
    PubMed     Text format     Abstract available


    February 2017
  95. NAZIR HF, Elshinawy M, AlRawas A, Khater D, et al
    Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000804.
    PubMed     Text format     Abstract available


  96. AL OMAR S, Anabtawi N, Al Qasem W, Rihani R, et al
    Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000792.
    PubMed     Text format     Abstract available


  97. DEMIRSOY U, Sarper N, Aylan Gelen S, Zengin E, et al
    The Association of Oral Vitamin D and Calcium Supplementation With Bone Mineral Density in Pediatric Acute Lymphoblastic Leukemia Patients.
    J Pediatr Hematol Oncol. 2017 Feb 23. doi: 10.1097/MPH.0000000000000797.
    PubMed     Text format     Abstract available


  98. HORIBE K, Yumura-Yagi K, Kudoh T, Nishimura S, et al
    Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
    J Pediatr Hematol Oncol. 2017 Feb 6. doi: 10.1097/MPH.0000000000000760.
    PubMed     Text format     Abstract available


    January 2017
  99. MCNERNEY KO, Vasquez JC, Kent MW, McNamara JM, et al
    Sinusoidal Obstruction Syndrome During Maintenance Therapy for Acute Lymphoblastic Leukemia With 6-Mercaptopurine and Methotrexate: A Pediatric Case Report.
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000776.
    PubMed     Text format     Abstract available


  100. DUJUA AC, Hernandez FG
    Survival Outcome of Filipino Children With Acute Lymphoblastic Leukemia Treated With Modified Berlin-Frankfurt-Muenster/Hong Kong Acute Lymphoblastic Leukemia (BFM95/HKALL97) Protocol in a Tertiary General Hospital From January 2005 to December 2009:
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000751.
    PubMed     Text format     Abstract available


  101. KODURU PR, Wilson K, Wen J, Garcia R, et al
    Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000770.
    PubMed     Text format     Abstract available


  102. VIOLA A, Balsamo L, Neglia JP, Brouwers P, et al
    The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.
    J Pediatr Hematol Oncol. 2017 Jan 12. doi: 10.1097/MPH.0000000000000761.
    PubMed     Text format     Abstract available


  103. JANCZAR S, Zalewska-Szewczyk B, Mlynarski W
    Severe Hyponatremia in a Single-Center Series of 84 Homogenously Treated Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000758.
    PubMed     Text format     Abstract available


  104. RASHED WM, Zekri W, Awad M, Taha H, et al
    Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000699.
    PubMed     Text format     Abstract available


  105. EBBESEN MS, Nygaard U, Rosthoj S, Sorensen D, et al
    Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000733.
    PubMed     Text format     Abstract available


  106. KASSAR O, Hammemi R, Ben Dhaou M, Kammoun S, et al
    Spontaneous Fracture and Migration of a Totally Implanted Port Device to Pulmonary Artery in Acute Leukemia Child.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000734.
    PubMed     Text format     Abstract available


  107. CZOGALA M, Balwierz W, Sztefko K, Rogatko I, et al
    Antithrombin III as the Indicator of L-Asparaginase Activity in Children Treated for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Jan 5. doi: 10.1097/MPH.0000000000000739.
    PubMed     Text format     Abstract available


  108. HUANG JG, Yeoh AE, Tambyah PA, Suhaila MI, et al
    The Conundrum in the Diagnosis and Management of Atypical Fulminant Measles in a Leukemia Survivor on Maintenance Chemotherapy.
    J Pediatr Hematol Oncol. 2017;39:e36-e38.
    PubMed     Text format     Abstract available


  109. GRIMES A, Mirkheshti N, Chatterjee B, Tomlinson G, et al
    Paraneoplastic Galactorrhea in Childhood T-ALL: An Evaluation of Tumor-derived Prolactin.
    J Pediatr Hematol Oncol. 2017;39:e18-e20.
    PubMed     Text format     Abstract available


  110. FOSTER JH, Bernhardt MB, Thompson PA, Smith EO, et al
    Using a Bedside Algorithm to Individually Dose High-dose Methotrexate for Patients at Risk for Toxicity.
    J Pediatr Hematol Oncol. 2017;39:72-76.
    PubMed     Text format     Abstract available


    November 2016
  111. AL-SWEEDAN S, Al-Seraihy A, Al-Ahmari A, Al-Jefri A, et al
    Factors Determining the Outcome of Hematopoietic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia at King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  112. SCHULTZ KA, Chen L, Kunin-Batson A, Chen Z, et al
    Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  113. BRIERLEY CK, Revuelta Iniesta R, Storrar N, Thomas AE, et al
    Hyperferritinemia in Pediatric Acute Lymphoblastic Leukemia: What Does it Mean?
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


  114. VATSAYAN A, Gupta A, Ahuja S, Egler R, et al
    Epstein-Barr Virus-associated Mucocutaneous Ulcer in a Patient With T-Cell Acute Lymphoblastic Leukemia: Importance of Accurate Diagnosis and Conservative Management.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  115. JENSEN TS, Arendrup MC, von Buchvald C, Frandsen TL, et al
    Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  116. PERKINS JL, Harris A, Pozos TC
    Immune Dysfunction After Completion of Childhood Leukemia Therapy.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  117. DAS A, Bansal D, Sreedharanunni S, Naseem S, et al
    Philadelphia Chromosome in an Infant With Pro-B Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


  118. ROBIN AJ, Peterson JF, Grignon JW Jr, Gheorghe G, et al
    Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  119. EL-FATTAH MA
    Survival Pattern of Chronic Myeloid Leukemia in a Pediatric Population in the United States.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


    August 2016
  120. LEVINSEN M, Harila-Saari A, Grell K, Jonsson OG, et al
    Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  121. BARDELLINI E, Amadori F, Schumacher RF, D'Ippolito C, et al
    Efficacy of a Solution Composed by Verbascoside, Polyvinylpyrrolidone (PVP) and Sodium Hyaluronate in the Treatment of Chemotherapy-induced Oral Mucositis in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  122. NAYIAGER T, Barr RD, Anderson L, Cranston A, et al
    Physical Activity in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  123. OSONE S, Imamura T, Kanayama T, Tsuma Y, et al
    Sorafenib Therapy for Pediatric Acute Myeloid Leukemia with FMS-like Tyrosine Kinase 3-internal Tandem Duplication Mutations: 2 Case Reports.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  124. LYNGGAARD LS, Marquart HV, Kjeldsen E, Madsen HO, et al
    Acute Lymphoblastic Leukemia Presenting With Pancytopenia Followed by a 14-Month-Long Period of Transient Remission Possibly Supporting the Adrenal Hypothesis of Leukemogenesis.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  125. XIA M, Zhang H, Lu Z, Gao Y, et al
    Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016;38:418-22.
    PubMed     Text format     Abstract available


    July 2016
  126. JABEEN K, Ashraf MS, Iftikhar S, Belgaumi AF, et al
    The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  127. ELBAHLAWAN LM, Avent Y, Montoya L, Wilder K, et al
    Safety and Benefits of Bronchoalveolar Lavage and Lung Biopsy in the Management of Pulmonary Infiltrates in Children With Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  128. SHULMAN DS, Lee MA, Lehmann LE, Margossian SP, et al
    Outcomes Following Bone Marrow Transplantation in Children With Accelerated Phase or Blast Crisis Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  129. YEO KK, Gaynon PS, Fu CH, Wayne AS, et al
    Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.
    J Pediatr Hematol Oncol. 2016;38:345-9.
    PubMed     Text format     Abstract available


    June 2016
  130. HONG D, Zhou C, He H, Wang Y, et al
    A 10-Year Follow-up Survey of Treatment Abandonment of Children With Acute Myeloid Leukemia in Suzhou, China.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  131. RODRIGUEZ V, Kairalla J, Salzer WL, Raetz EA, et al
    A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  132. VUNDAMATI D, Bostrom B
    Prolonged Response in Patient With Multiply Relapsed B-cell Acute Lymphoblastic Leukemia and Monosomy-7 to Bortezomib, Lenalidomide, and Dexamethasone.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  133. AL-EITAN LN, Rababa'h DM, Alkhatib RQ, Khasawneh RH, et al
    GSTM1 and GSTP1 Genetic Polymorphisms and Their Associations With Acute Lymphoblastic Leukemia Susceptibility in a Jordanian Population.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  134. ACHARYA S, Hsieh S, Shinohara ET, DeWees T, et al
    Effects of Race/Ethnicity and Socioeconomic Status on Outcome in Childhood Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  135. KOLENOVA A, Maloney KW, Hunger SP
    Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  136. BADAWY SM
    The Use of Hydroxyurea and Leukapheresis in Childhood Acute Leukemia With Hyperleukocytosis.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


    March 2016
  137. WEDEKIND MF, Dennis R, Sturm M, Koch T, et al
    The Effects of Hospital Length of Stay on Readmissions for Children With Newly Diagnosed Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  138. BROWN AL, Lupo PJ, Danysh HE, Okcu MF, et al
    Prevalence and Predictors of Overweight and Obesity Among a Multiethnic Population of Pediatric Acute Lymphoblastic Leukemia Survivors: A Cross-Sectional Assessment.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  139. SUN B, Li L, Xu M, Wang X, et al
    Significance of BAFF/APRIL Expression and Their Receptors in Pediatric Patients With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  140. ABLA O, Angelini P, Di Giuseppe G, Kanani MF, et al
    Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
    J Pediatr Hematol Oncol. 2016;38:111-7.
    PubMed     Text format     Abstract available


    February 2016
  141. MACDONALD T, Kulkarni K, Bernstein M, Fernandez CV, et al
    Allergic Reactions With Intravenous Compared With Intramuscular Pegaspargase in Children With High-risk Acute Lymphoblastic Leukemia: A Population-based Study From the Maritimes, Canada.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  142. RAMAMOORTHY J, Jain R, Trehan A, Saxena AK, et al
    Orbital Mass in a Child With Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  143. SMITHERMAN AB, Wilkins TM, Blatt J, Dusetzina SB, et al
    Early Posttherapy Hospitalizations Among Survivors of Childhood Leukemia and Lymphoma.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  144. TAVIL B, Isgandarova F, Bayhan T, Unal S, et al
    Sorafenib-induced Posterior Reversible Encephalopathy Syndrome in a Child With FLT3-ITD-positive Acute Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  145. BISS TT, Payne JH, Hough RE, Grainger JD, et al
    Strategies to Prevent and Manage Thrombotic Complications of Acute Lymphoblastic Leukemia in Children and Young People Vary Between Centers in the United Kingdom.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  146. HEFTI E, Blanco JG
    Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  147. BOUCHER MO, Smitherman AB, Pahl KS, Rao KW, et al
    RUNX1 Amplification Increases the Risk for Thrombosis in Children With B-cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  148. MONFRIES N, Belletrutti M, McKillop S
    Surgery as a Recurrent Trigger for Immune Thrombocytopenia (ITP) in a Patient Cured of M7 Acute Myelogenous Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  149. BERGMANN K, Hasle H, Asdahl P, Handrup MM, et al
    Central Venous Catheters and Bloodstream Infection During Induction Therapy in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  150. TAGIYEV A, Demirbilek H, Tavil B, Buyukyilmaz G, et al
    Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  151. TSEPIS K, Tragiannidis A, Gombakis N, Hatzistilianou M, et al
    Early-onset SMART Syndrome in an 11-Year-Old Child With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format    


    January 2016
  152. GIAMANCO NM, Cunningham BS, Klein LS, Parekh DS, et al
    Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  153. LAM GK, Leung AW, Ha SY, Luk CW, et al
    Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
    J Pediatr Hematol Oncol. 2016.
    PubMed     Text format     Abstract available


  154. WILLIAMS M, Khalid T, Hughes S, Bonney D, et al
    Rituximab-induced Cytokine Storm in the Absence of Overt Lymphoproliferative Disease.
    J Pediatr Hematol Oncol. 2016;38:e29-31.
    PubMed     Text format     Abstract available


  155. VUILLE-DIT-BILLE RN, Berger C, Meuli M, Grotzer MA, et al
    Colostomy for Perianal Sepsis With Ecthyma Gangrenosum in Immunocompromised Children.
    J Pediatr Hematol Oncol. 2016;38:53-7.
    PubMed     Text format     Abstract available


  156. ANDINA D, Lassaletta A, Sevilla J, Gutierrez S, et al
    Hemiparesis in an Adolescent With Acute Lymphoblastic Leukemia: Everything Is Not Always What it Seems.
    J Pediatr Hematol Oncol. 2016;38:63-4.
    PubMed     Text format     Abstract available


    October 2015
  157. DOMENECH C, Leick-Courtois C, Bienvenu AL, Pracros JP, et al
    Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review.
    J Pediatr Hematol Oncol. 2015;37:560-5.
    PubMed     Text format     Abstract available


  158. YEUNG AK, Guilcher GM, deBruyn JC
    Conservative Management of Downhill Esophageal Varices Secondary to Central Line-related Thrombosis After Hematopoietic Stem Cell Transplant.
    J Pediatr Hematol Oncol. 2015;37:e424-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: